The purpose of this study is to create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and then screen this cohort for pancreatic cancer
Compared to the general population, subjects \>50 years of age with new-onset diabetes (DM) are 8-times more likely to have pancreatic cancer (PaC). The likelihood of PaC in new-onset DM is further increased in those who have weight loss or elevated CA19-9. In this study patients with newly diagnosed diabetes will be prospectively identified. Those with weight loss and/or elevated pancreatic cancer marker (CA 19-9) will undergo pancreatic imaging. All subjects will be followed up to 24 months. If successful in identifying surgically removable PaC, this study will fundamentally change our practice and will be a major breakthrough in PaC treatment and research.
Study Type
OBSERVATIONAL
Enrollment
79
baseline, quarterly follow-up for 24 months
baseline
baseline
Mayo Clinic in Rochester
Rochester, Minnesota, United States
To create a prospective cohort of subjects with increased probability of being diagnosed with pancreatic cancer and identify pancreatic cancer in this cohort.
We will prospectively identify patients with newly diagnosed diabetes and perform pancreatic imaging to identify pancreatic cancer
Time frame: Follow subjects for 2 years.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.